Pientzehuang invests in Zhaoying Fund in RMB 200m deal

Zhangzhou Pientzehuang Pharmaceutical (SSE:600436) announced that its wholly-owned subsidiary, Zhangzhou Pientzehuang Investment Management Co., Ltd., will invest CNY 200 million in the Zhaoying Huikang Equity Investment Partnership Enterprise (Limited Partnership), also known as Zhaoying Fund, with the investment representing 20% of the fund's target size. The fund will focus on investments in sectors including biomedicine, traditional Chinese medicine, medical devices, and healthcare services. The investment constitutes a related party transaction due to involvement of Zhangzhou Pientzehuang Asset Management Co., Ltd., and Zhangzhou Tourism Investment Group Co., Ltd. The board has approved the investment, with related directors abstaining.